Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Kim

Showing results (241-250 of 269) with videos related to

Pageof 27
Sort By:
American Journal of Epidemiology|May 20, 2017
Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis BMohamed A Hassan, W Ray Kim, Ruosha Li, et al.
Hepatology (Baltimore, Md.)|February 29, 2012
Model to estimate survival in ambulatory patients with hepatocellular carcinomaJu Dong Yang, W Ray Kim, Kyung Woo Park, et al.
Hepatology (Baltimore, Md.)|October 12, 2012
Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer riskRoongruedee Chaiteerakij, Ju Dong Yang, William S Harmsen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2020
Introducing EL-FIT (Exercise and Liver FITness): A Smartphone App to Prehabilitate and Monitor Liver Transplant CandidatesAndrés Duarte-Rojo, Pamela M Bloomer, Renee J Rogers, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 3, 2023
OPTN/SRTR 2021 Annual Data Report: LiverAllison J Kwong, Noelle H Ebel, W Ray Kim, et al.
Hepatology (Baltimore, Md.)|March 19, 2025
Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver diseaseAlina M Allen, W Ray Kim, Patrizia Carrieri, et al.
Cancer|July 17, 2015
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis BW Ray Kim, Rohit Loomba, Thomas Berg, et al.
Hepatology Communications|April 21, 2022
First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamideCalvin Q Pan, Nezam H Afdhal, Victor Ankoma-Sey, et al.
Transplantation|October 30, 2023
Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction ModelsMai Sedki, Allison Kwong, Meera Bhargava, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2015
Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE studyJ Ahn, H M Lee, J K Lim, et al.
Pageof 27

Showing results (241-250 of 269) with videos related to

Sort By:
Pageof 27
American Journal of Epidemiology|May 20, 2017
Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis BMohamed A Hassan, W Ray Kim, Ruosha Li, et al.
Hepatology (Baltimore, Md.)|February 29, 2012
Model to estimate survival in ambulatory patients with hepatocellular carcinomaJu Dong Yang, W Ray Kim, Kyung Woo Park, et al.
Hepatology (Baltimore, Md.)|October 12, 2012
Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer riskRoongruedee Chaiteerakij, Ju Dong Yang, William S Harmsen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2020
Introducing EL-FIT (Exercise and Liver FITness): A Smartphone App to Prehabilitate and Monitor Liver Transplant CandidatesAndrés Duarte-Rojo, Pamela M Bloomer, Renee J Rogers, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 3, 2023
OPTN/SRTR 2021 Annual Data Report: LiverAllison J Kwong, Noelle H Ebel, W Ray Kim, et al.
Hepatology (Baltimore, Md.)|March 19, 2025
Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver diseaseAlina M Allen, W Ray Kim, Patrizia Carrieri, et al.
Cancer|July 17, 2015
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis BW Ray Kim, Rohit Loomba, Thomas Berg, et al.
Hepatology Communications|April 21, 2022
First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamideCalvin Q Pan, Nezam H Afdhal, Victor Ankoma-Sey, et al.
Transplantation|October 30, 2023
Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction ModelsMai Sedki, Allison Kwong, Meera Bhargava, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2015
Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE studyJ Ahn, H M Lee, J K Lim, et al.
Pageof 27